Tasly Cerebralcare Granules

Published date: April 16, 2021

Body Products

Nigeria, Lagos, Alimosho

35 LIASU ROAD

Views: 175

₦ 7,920.00

TASLY HEALTH TCM

User

Register date: January 6, 2021

Description

Functions
1. Relieve headaches caused by various reasons.


2. Improve cerebral circulation, enhance blood and oxygen supply, and help to improve chronic cerebral circulation insufficiency(CCCI).


3. Help to prevent cerebrovascular diseases and recovery from stroke.

Advantages
• Advanced technology and quality control system
• Multiple effects proved by clinical research
• No side effects
• Sugar free and safe for diabetes

Target Groups
• People desiring to protect cerebral function
• People with chronic cerebral circulation insufficiency
• People suffering from various type of headache, dizziness and vertigo
• People with stroke
• Elderly people with cognitive or memory disorders intending to prevent dementia
• Hypertensives
• People unable to sleep
• People subjected to emotional disorders like anxiety and depression

Dosage 
Dissolve the contents of 1 sachet into a cup of lukewarm boiled water. Take 1 sachet, 2 to 3 times daily before meals.

Notes
Do not use with low blood pressure except under medical supervision.
Do not use during pregnancy or while breast feeding.
NOT recommended for children under the age of 12 years old.

Package
4g x 10 sachets


Cash on delivery within Lagos.
Delivery outside Lagos or Nigeria is based on agreement.

Can chat or CALL phone no to place order or ask questions.


Phone no: 08029112894
Negotiable:
Send messageto seller

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Comments

0 Comments